IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Last updated 25 setembro 2024
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
Tweak to Treat: Reprograming Bacteria for Cancer Treatment: Trends in Cancer
HLA-G/LILRBs: A Cancer Immunotherapy Challenge: Trends in Cancer
PDF) IL-3 is a novel target to interfere with tumor vasculature
Antibody–drug conjugates: in search of partners of choice: Trends in Cancer
The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer: Trends in Cancer
Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
IJMS, Free Full-Text
Frontiers Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Recomendado para você
você pode gostar